New award for ranibizumab (lucentis) syringes with genentech USA, INC. Period of performance is 12/23/23 to 12/22/24 with four one-year options.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79724D0001
- Awardee
-
Genentech Usa, Inc. UEI SA85BMHCTXK5
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Ranibizumab Pre-Solicitation · 36E79723R0018 · Posted Jun 15, 2023
- Last date to order 94% complete
- IDV ceiling
- $3,011,580.00
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The General Services Administration's National Acquisition Center awarded a single-award indefinite-delivery contract to Genentech USA, Inc. for Ranibizumab (Lucentis) syringes on December 23, 2023, with a ceiling value of $3,011,580.
The contract carries no set-aside. Performance runs from December 23, 2023 through December 22, 2024, with four one-year options extending the potential completion date to December 22, 2028. Work is performed at Genentech's South San Francisco, California facility. The contract implements Executive Order 14398 regarding discrimination and diversity initiatives.
The solicitation, posted as a pre-solicitation notice on June 15, 2023 with responses due July 13, 2023, sought reliable supply of Ranibizumab (Lucentis) injectables for federal healthcare and pharmaceutical stockpiling programs. Genentech manufactures the product as a pharmaceutical preparation within NAICS 325412 and supplies it exclusively as a prime contractor to federal agencies under open-competition vehicles with no subcontractor involvement.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Original award | $0 |
Show all 13
Quick answers
Who was awarded contract 36E79724D0001?
36E79724D0001 was awarded to Genentech Usa, Inc. by National Acquisition Center (Headquarters) on December 23, 2023.
How much is contract 36E79724D0001 worth?
36E79724D0001's own ceiling is $3,011,580.
Who can order from contract 36E79724D0001?
36E79724D0001 is a single award indefinite delivery contract.
Was contract 36E79724D0001 competed?
The extent of competition for 36E79724D0001 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV